Ovarian Hyperstimulation for in Vitro Fertilization Preceded by Prolonged Administration of a Gonadotropin-Releasing Hormone Agonist

References

• Rutherford A J, Subak-Sharpe R J, Dawson K J, Margara R A, Franks S, Winston R ML. Improvement of in vitro fertilization after treatment with buserelin, an agonist of luteinising hormone releasing hormone. Br Med J 1988; 296: 1765–8
   PubMed Web of Science ®Google Scholar
• MacNamee M C, Edwards R G, Howls C M. The influence of stimulation regimes and luteal phase support on the outcome of IVF. Hum Reprod 1988; 3(suppl 2)43–52
   Google Scholar
• Åbyholm T, Tanbo T, Dale P O, Kjekshus E. The first attempt at IVF treatment. Results and requirements for a satisfactory success rate. Eur J Obstet Gynecol Reprod Biol
   Google Scholar
• Fleming R, Coutts J RT. Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression. Fertil Steril 1986; 45: 226–30
   PubMed Web of Science ®Google Scholar
• Smitz J, Devroey P, Camus M, Khan I, Staessen C, Van Waesberge L, Wisanto A, Van Steirteghem A C. Addition of Buserelin to human menopausal gonadotropins in patients with failed stimulations for IVF or GIFT. Hum Reprod 1988; 3(suppl 2)35–8
   Google Scholar
• MacLachlan V, Besanko M, O'Shea F, Wade H, Wood C, Trounson A, Healy D L. A controlled study of luteinizing hormone-releasing hormone agonist (buserelin) for the induction of folliculogenesis before in vitro fertilization. N Engl J Med 1989; 320: 1233–7
   Google Scholar
• Belaisch-Allart J, Testart J, Frydman R. Utilization of GnRH agonists for poor responders in an IVF programme. Hum Reprod 1989; 4: 33–4
   PubMed Web of Science ®Google Scholar
• Serafini P, Stone B, Kerin J, Batzofin J, Quinn P, Marrs R P. An alternate approach to controlled ovarian hyperstimulation in “poor responders”: pretreatment with a gonadotropin-releasing hormone analog. Fertil Steril 1988; 49: 90–4
   PubMed Web of Science ®Google Scholar
• Tanbo T, Dale P O, Åyholm T, Stokke K T. Follicle-stimulating hormone as a prognostic indicator in clomiphene citrate/human menopausal gonadotropin-stimulated cycles for in-vitro fertilization. Hum Re-prod 1989; 4: 647–50
   Google Scholar
• Tanbo T, Henriksen T, Magnus Ø, Åbyholm T. Oocyte retrieval in an IVF program. A comparison of laparoscopic and transvaginal ultrasound-guided follicular puncture. Acta Obstet Gynecol Scand 1988; 67: 243–6
   PubMed Web of Science ®Google Scholar
• Fraser H M, Waxman J. Gonadotropin releasing hormone analogues for gynaecological disorders and infertility. A real advance. Br Med J 1989; 298: 475–6
   PubMedGoogle Scholar
• Hodgen G D. General applications of GnRH agonists in gynecology: past, present and future. Obstet Gynecol Survey 1989; 44: 293–6
   Google Scholar
• Frydman R, Parneix I, Belaisch-Allart J, Forman R, Hazout A, Fernandez H, Testart J. LHRH agonists in IVF: different methods of utilization and comparison with prevous ovulation stimulation treatments. Hum Reprod 1988; 3: 559–61
   PubMed Web of Science ®Google Scholar
• Loumaye E, De Cooman S, Anoma M, Psalti I, Depreester S, Schmit M, Thomas K. Short-term utilization of a gonadotropin-releasing hormone agonist (buserelin) for induction of ovulation in an in vitro fertilization program. Ann N Y Acad Sci 1988; 541: 96–102
   Google Scholar
• Neveu S, Hedon B, Bringer J, Chinchole J M, Arnal F, Humeau C, Cristol P, Viala J L. Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization. Fertil Steril 1987; 47: 639–43
   PubMed Web of Science ®Google Scholar
• Piette C, de Mouzon J, Bachelot A, Spira A. In-vitro fertilization: influence of women's age on pregnancy rates. Hum Reprod 1990; 5: 56–9, FIVNAT by
   PubMed Web of Science ®Google Scholar
• Monroe S C, Blumenfeld Z, Andreyko J L, Schriock E, Henzl M R, Jaffe R B. Dose-dependent inhibition of pituitary-ovarian function during administration of a gonadotropin-releasing hormone agonistic analog (Na-farelin). J Clin Endocrinol Metab 1986; 63: 1334–41
   PubMed Web of Science ®Google Scholar
• Navot D, Rosenwaks Z, Margalioth E J. Prognostic assessment of female fecundity. Lancet 1987; ii: 645–7
   Google Scholar
• Tanbo T, Åbyholm T, Bjøro T, Dale P O. Ovarian superstimulation in previous failures from in-vitro fertilization. Distinction of two groups of poor responders. Hum Reprod
   Google Scholar
• Crosignani P G, Ragni G, Lombroso G C, Scarduelli C, De Lauretis L, Caccamo A, Dalpra L, Cavioni V, Cristiani C, Wyssling H, Olivares M D, Perotti L. Ovarian stimulation of IVF patients: effects of the reversible hypogonadotropic state induced by GnRH agonist. Hum Reprod 1988; 3(suppl 2)39–41
   Google Scholar
• Pellicer A, Ruiz A, Castellvi R M, Calatayud C, Ruiz M, Tarin J J, Miro F, Bonilla-Musoles F. is the retrieval of high numbers of oocytes desirable in patients with gonadotropin-releasing hormone analogues (GnRHa) and gonadotropins. Hum Reprod 1989; 4: 536–40
   PubMed Web of Science ®Google Scholar
• Droesch K, Muasher S J, Brzyski R G, Jones G S, Simonetti S, Liu H C, Rosenwaks Z. Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization. Fertil Steril 1989; 51: 292–7
   PubMed Web of Science ®Google Scholar
• Lanzone A, Fulghesu A M, Spina M A, Apa R, Menini E, Caruso A, Mancuso S. Successful induction of ovulation and conception with combined gonadotropin-releasing hormone agonist plus highly purified follicle-stimulating hormone in patients with polycystic ovarian disease. J Clin Endocrinol Metab 1987; 65: 1253–8
   PubMed Web of Science ®Google Scholar
• Testart J, Forman R, Belaish-Allart J, Volante M, Hazout A, Strubb N, Frydman R. Embryo quality and uterine receptivity in in-vitro fertilization cycles with or without agonists of gonadotropin-releasing hormone. Hum Reprod 1989; 4: 198–201
   Google Scholar